Russell Investments Group Ltd. continued to hold its position in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 93,232 shares of the medical equipment provider’s stock at the end of the second quarter. Russell Investments Group Ltd.’s holdings in Smith & Nephew SNATS were worth $3,249,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Pictet Asset Management Ltd. increased its position in shares of Smith & Nephew SNATS by 139.8% in the first quarter. Pictet Asset Management Ltd. now owns 224,223 shares of the medical equipment provider’s stock worth $6,935,000 after buying an additional 130,724 shares during the period. Comerica Bank increased its position in shares of Smith & Nephew SNATS by 1.8% in the first quarter. Comerica Bank now owns 32,120 shares of the medical equipment provider’s stock worth $1,064,000 after buying an additional 578 shares during the period. Cambiar Investors LLC increased its position in shares of Smith & Nephew SNATS by 6.2% in the first quarter. Cambiar Investors LLC now owns 5,143,756 shares of the medical equipment provider’s stock worth $159,096,000 after buying an additional 301,213 shares during the period. Suntrust Banks Inc. increased its position in shares of Smith & Nephew SNATS by 31.4% in the first quarter. Suntrust Banks Inc. now owns 75,994 shares of the medical equipment provider’s stock worth $2,348,000 after buying an additional 18,138 shares during the period. Finally, Bank of New York Mellon Corp increased its position in shares of Smith & Nephew SNATS by 3.9% in the first quarter. Bank of New York Mellon Corp now owns 66,199 shares of the medical equipment provider’s stock worth $2,048,000 after buying an additional 2,509 shares during the period. 6.36% of the stock is owned by hedge funds and other institutional investors.

Smith & Nephew SNATS, Inc. (NYSE:SNN) traded down 0.28% during midday trading on Tuesday, hitting $35.77. The stock had a trading volume of 236,087 shares. Smith & Nephew SNATS, Inc. has a 12-month low of $26.97 and a 12-month high of $36.22. The company has a market cap of $15.66 billion, a price-to-earnings ratio of 18.21 and a beta of 0.76. The company has a 50-day moving average price of $35.14 and a 200-day moving average price of $33.36.

The business also recently announced a semiannual dividend, which will be paid on Wednesday, November 1st. Stockholders of record on Friday, October 6th will be issued a $0.246 dividend. The ex-dividend date of this dividend is Thursday, October 5th. This represents a dividend yield of 1.37%.

COPYRIGHT VIOLATION NOTICE: “Russell Investments Group Ltd. Holds Stake in Smith & Nephew SNATS, Inc. (SNN)” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.watchlistnews.com/russell-investments-group-ltd-holds-stake-in-smith-nephew-snats-inc-snn/1530127.html.

Several equities research analysts have recently weighed in on SNN shares. Zacks Investment Research raised Smith & Nephew SNATS from a “hold” rating to a “buy” rating and set a $40.00 price objective for the company in a report on Wednesday, June 7th. BidaskClub raised Smith & Nephew SNATS from a “buy” rating to a “strong-buy” rating in a report on Friday, June 23rd. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Smith & Nephew SNATS presently has a consensus rating of “Buy” and an average target price of $38.00.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.